Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹852 Cr₹1,097 Cr₹747 Cr₹768 Cr₹704 Cr

What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS is ₹852 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹852 Cr
Mar2024₹1,097 Cr
Mar2023₹747 Cr
Mar2022₹768 Cr
Mar2021₹704 Cr

How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹852 Cr
-22.38
Mar2024 ₹1,097 Cr
46.92
Mar2023 ₹747 Cr
-2.78
Mar2022 ₹768 Cr
9.05
Mar2021 ₹704 Cr -

Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,899.6 Cr -2.5% 2.5% 57.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.5%

2.5%

57.6%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses